Credit Suisse’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.36M | Buy |
|
|||||
|
2023
Q4 | $1.64M | Sell |
|
|||||
|
2023
Q3 | $1.06M | Sell |
|
|||||
|
2023
Q2 | $1.84M | Buy |
|
|||||
|
2023
Q1 | $892K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $148K | Sell |
|
|||||
|
2021
Q4 | $231K | Buy |
|
|||||
|
2021
Q3 | $279K | Buy |
|
|||||
|
2021
Q2 | $237K | Sell |
|
|||||
|
2021
Q1 | $413K | Sell |
|
|||||
|
2020
Q4 | $849K | Sell |
|
|||||
|
2020
Q3 | $1.26M | Buy |
|
|||||
|
2020
Q2 | $1.35M | Buy |
|
|||||
|
2020
Q1 | $585K | Sell |
|
|||||
|
2019
Q4 | $1.12M | Buy |
|
|||||
|
2019
Q3 | $270K | Buy |
|
|||||
|
2019
Q2 | $286K | Sell |
|
|||||
|
2019
Q1 | $378K | Buy |
|
|||||
|
2018
Q4 | $233K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $821K | Buy |
|